Lucchese, Guglielmo
 Distribuzione geografica
Continente #
AS - Asia 232
EU - Europa 20
NA - Nord America 1
Totale 253
Nazione #
HK - Hong Kong 231
IT - Italia 15
CH - Svizzera 1
DE - Germania 1
FR - Francia 1
NL - Olanda 1
RU - Federazione Russa 1
SG - Singapore 1
US - Stati Uniti d'America 1
Totale 253
Città #
Hong Kong 231
Pescara 3
Bari 2
Rome 2
Ashburn 1
Geneva 1
Nuremberg 1
Totale 241
Nome #
Impact of COVID‑19 emergency on the psychological well‑being of susceptible individuals 9
Anti-Platelet Factor 4 Antibodies Causing VITT do not Cross-React with SARS-CoV-2 Spike Protein. 7
Zusammensetzungen zur Behandlung von COVID-19-assoziierter Autoimmun-Hirnstamm- Enzephalitis 6
Bacterial peptides are intensively present throughout the human proteome 6
Comparison of dry and wet electroencephalography for the assessment of cognitive evoked potentials and sensor-level connectivity 6
Brain oscillatory processes related to sequence memory in healthy older adults 6
Anti-neuronal antibodies against brainstem antigens are associated with COVID-19 6
Natural history of multiple sclerosis: have available therapies impacted long-term prognosis? 6
Reconciling forgetting and memory consolidation: simulating the dissociable effects of neuronal noise levels on cortical memory 6
Differential effects of intensive language-action therapy on processing grammatical word class and semantics demonstrated by functional magnetic resonance imaging 6
Changes of Cognitive Performances, Fatigue and Health Related Quality of Life in Natalizumab-Treated Relapsing Multiple Sclerosis Patients 5
Charting the peptide crossreactome between HIV-1 and the human proteome 5
A peptide link between HCMV infection, neuronal migration, and psychosis 5
Clinical applications of DNA microarray analysis 5
A peptide talk between JC virus and the human host: from silent infection to autoimmunity 5
Anti–platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein 5
Cerebrospinal fluid findings in COVID-19 indicate autoimmunity 5
Chapter 33 - Impact of COVID-19 on the brain: Antibodies against brain stem antigens 5
A spiking neurocomputational model of high-frequency oscillatory brain responses to words and pseudowords 5
Seroprevalence of vector-borne pathogens in outdoor workers from southern Italy and associated occupational risk factors. 5
An Epitope Platform for Safe and Effective HTLV-1-Immunization: Potential Applications for mRNA and Peptide-Based Vaccines 5
Confronting JC virus and Homo sapiens biological signatures 5
An epitope platform for safe and effective HTLV-1-immunization: Potential applications for mRNA and peptide-based vaccines 5
Increased recruitment of domain general neural networks in language processing following Intensive Language-Action Therapy – fMRI evidence from people with chronic aphasia 4
Reconciling forgetting and memory consolidation: Simulating the dissociable effects of neuronal noise levels on cortical memory traces 4
H1N1 versus H5N1 hemagglutinins: A possible differential immunologic impact on neurodevelopment 4
Immune Response Against SARS-CoV-2 4
Developing an anti-Campylobacter jejuni vaccine 3
Reply concerning the article "Zika virus and autoimmunity: From microcephaly to Guillain-Barré syndrome, and beyond" 3
Seroprevalence of vector-borne pathogens in outdoor workers from southern Italy and associated occupational risk factors 3
Intensive social interaction for treatment of post-stroke depression in subacute aphasia: The CONNECT trial 3
Therapy-Induced Neuroplasticity of Language in Chronic Post Stroke Aphasia: A Mismatch Negativity Study of (A)Grammatical And Meaningful/less Mini-Constructions 3
Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons 3
Neuropragmatic Speech-Language Deficits Specific To Speech Act Type Following Left-Hemispheric Lesion 3
Identification of monoclonal anti-HMW-MAA antibody linear peptide epitope by proteomic database mining 3
Communicative-pragmatic assessment is sensitive and time-effective in measuring the outcome of aphasia therapy 3
Epitopes for a 2019-nCoV vaccine 3
Gender ratio of Multiple Sclerosis in Italy: geographical distribution and trend over 60 years 3
The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude 3
Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection. 3
Efficacy of intensive aphasia therapy in patients with chronic stroke: a randomised controlled trial 3
Geographic Differences in the Temporal Trend of Gender Ratio in Multiple Sclerosis 3
Peptide matching between Epstein–Barr virus and human proteins 3
Cross-Reactivity as a Mechanism Linking Infections to Stroke 3
Searching for an effective, safe and universal anti-HIV vaccine: Finding the answer in just one short peptide 3
The peptide network between tetanus toxin and human proteins associated with epilepsy 3
Zika virus and autoimmunity: From microcephaly to Guillain-Barre syndrome, and beyond 3
Sub-epitopic dissection of HCV E1315-328HRMAWDMMMNWSPT sequence by similarity analysis 3
EBV-Associated Cancer and Autoimmunity: Searching for Therapies 3
Degenerate binding of tyrosinase peptides to MHC II Ad/Ed molecules 3
No human protein is exempt from bacterial motifs, not even one 3
Sex ratio of multiple sclerosis: a comparison of distribution and trend over 60 years among different countries 3
Peptidology: short amino acid modules in cell biology and immunology 3
Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome 3
Circumscribing the conformational peptide epitope landscape 3
Understanding neuropsychiatric diseases, analyzing the peptide sharing between infectious agents and the Language-associated NMDA 2A protein 3
Does communication make aphasia therapy more efficient?: Evidence from a cross-over randomized controlled trial 3
Neuropragmatic Speech-Language Deficits Specific To Speech Act Type Following Left-Hemispheric Lesion 3
Massive peptide sharing between viral and human proteomes 3
SARS-CoV-2 and Guillain-Barré Syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism 3
Widespread and ample peptide overlapping between HCV and Homo sapiens proteomes 3
Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response 3
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis 3
Single amino acid repeats connect viruses to neurodegeneration 3
Geographical variations in sex ratio trends over time in Multiple Sclerosis 3
Proteome-guided search for influenza A B-cell epitopes 3
Using language for communication and action makes intensive aphasia therapy more effective: a crossover randomized controlled trial 3
Herpesviruses, autoimmunity and epilepsy: Peptide sharing and potential cross-reactivity with human synaptic proteins 3
From Toxoplasmosis to Schizophrenia via NMDA Dysfunction: Peptide Overlap between T. gondii and NMDARs as a Potential Mechanistic Link 3
Electrophysiological correlates of language improvements after intensive language therapy in patients with chronic post-stroke aphasia 3
Early and interactive stored-form (symbol) access and combinatorial (rule) processing in constructing constructions: a MMN study 3
Sentence Construction by Stored-Form Retrieval and by Combination: ERP Evidence for Early and Interactive Processing 3
Using language for social interaction: Communication mechanisms promote recovery from chronic non-fluent aphasia 3
Peptide sharing between viruses and DLX Proteins: a potential cross-reactivity pathway to neuropsychiatric disorders 3
Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry 3
Natalizumab treatment affects cognitive performances, fatigue and health related quality of life in Relapsing Multiple Sclerosis 3
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry 3
PSYCHOLOGICAL GENERAL WELL-BEING, COGNITIVE FAILURE, AND INFLAMMATION BIOMARKERS AMONG WORKERS FOUR MONTHS AFTER A MILD/ASYMPTOMATIC SARS-CoV-2 INFECTION 3
Peptide Sharing Between Influenza A H1N1 Hemagglutinin and Human Axon Guidance Proteins 3
The Guillain–Barrè peptide signatures: from Zika virus to Campylobacter, and beyond 3
Potential Crossreactivity of Human Immune Responses Against HCMV Glycoprotein B 3
Epitopes for a 2019-nCoV vaccine 3
Electrophysiological Evidence for Early and Interactive Symbol Access and Rule Processing in Retrieving and Combining Language Constructions 3
Treating multiple sclerosis with natalizumab 3
Increasing age at disability milestones among MS patients in the MSBase Registry 3
Impact of natalizumab treatment on cognitive performance, fatigue and health-related quality of life in relapsing multiple sclerosis 3
Proposing low-similarity peptide vaccines against Mycobacterium tuberculosis 3
Peptide profiling of the route from Mahoney to Sabin, and return 3
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 3
Minimal immune determinants connect Zika virus, human Cytomegalovirus, and Toxoplasma gondii to microcephaly-related human proteins 3
West Nile virus diagnosis and vaccination: using unique viral peptide sequences to evoke specific immune responses 3
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study 3
Cytomegalovirus infection: The neurodevelopmental peptide signatures 3
Relationships between Plasma Osteopontin Levels and Cognitive Performances in Relapsing Multiple Sclerosis: Effect of Natalizumab Treatment 3
COVID19 outbreak in Lombardy, Italy: An analysis on the short-term relationship between air pollution, climatic factors and the susceptibility to SARS-CoV-2 infection 3
Verbal Fluency Impairment in Patients with Clinically Isolated Syndrome Suggestive of Multipla Sclerosis 3
How a single amino acid change may alter the immunological information of a peptide 3
Totale 355
Categoria #
all - tutte 2.666
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.666


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025355 0 0 0 104 4 230 17 0 0 0 0 0
Totale 355